Back to top

BioCryst Pharmaceuticals (BCRX) Looks Good: Stock Adds 6% in Session

Read MoreHide Full Article

BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.39 to $7.31 in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for BioCryst Pharmaceuticals. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

BioCryst Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

BioCryst Pharmaceuticals, Inc. Price

A better-ranked stock in the Medical-Drugs industry is BioSpecifics Technologies Corp. (BSTC - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BCRX going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


BioCryst Pharmaceuticals, Inc. (BCRX) - free report >>

BioSpecifics Technologies Corp (BSTC) - free report >>

More from Zacks Tale of the Tape

You May Like

Published in